| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 04/27/2000 | DE19837702A1 Duft- und Aromastoff Fragrance and flavor |
| 04/27/2000 | CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/26/2000 | EP0994862A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 04/26/2000 | EP0994848A1 Glucagon antagonists/inverse agonists |
| 04/26/2000 | EP0810998B1 Phenyl diketone derivatives as herbicides |
| 04/26/2000 | CN1051759C Process for preparing arylethanolamine |
| 04/25/2000 | US6054596 Reacting a diol with a carbonic ester; cyclization |
| 04/25/2000 | CA2001842C Cyclohexone oxime ethers, their preparation and their use as herbicides |
| 04/19/2000 | EP0993458A1 3-benzylpiperidine |
| 04/19/2000 | EP0993442A1 Hydrazine derivatives |
| 04/19/2000 | EP0993441A1 INHIBITORS OF p38 |
| 04/19/2000 | CN1251112A Cross-linked vinyl polymers with bile acid adsorbing effect |
| 04/18/2000 | US6051731 O-or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/18/2000 | US6051711 Acid hydrolysis in the presence of a c1-c4 alkanol to obtain a crystalline salt of swainsonine |
| 04/13/2000 | WO2000020477A1 Modified isocyanates |
| 04/13/2000 | WO2000020407A1 Process for the preparation of alkylene carbonate |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 04/13/2000 | CA2346443A1 Prostaglandin receptor ligands |
| 04/13/2000 | CA2345366A1 Modified isocyanates |
| 04/12/2000 | EP0992485A1 Chiral compounds |
| 04/12/2000 | EP0759917B1 Novel selective inhibitors of viral or bacterial neuraminidases |
| 04/12/2000 | CN1250444A 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (D4) |
| 04/12/2000 | CN1051300C Hydrazinecarboxamide derivatives use for agricultural and horticultural pesticide |
| 04/11/2000 | US6048893 Substituted phenyl compounds with a substituent having A 1,3-benzodioxole ring |
| 04/11/2000 | US6048882 Isoprenylamine compound |
| 04/11/2000 | US6048860 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| 04/06/2000 | WO2000018735A1 2-substituted heterocyclic sulfonamides |
| 04/06/2000 | WO2000018726A1 Method for preparing trion-bis(oxime ether) derivatives andrion-mono and trion-bis(oxime ether) derivatives obtained therewith |
| 04/05/2000 | EP0990465A2 Decomposition type reactive emulsifier and polymer-modifying method using the same |
| 04/05/2000 | EP0990439A1 Bisaryl compounds and cancer remedies containing the same |
| 04/05/2000 | EP0785923B1 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/05/2000 | CN1249742A Anti-inflammatory compounds |
| 04/05/2000 | CN1051074C Use of isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides for preparing medicine |
| 04/04/2000 | US6046127 Mixture comprising a polymethylhydrogensiloxane carbonyl moiety reducing agent and catalyst comprising transition metal compound complexed to metallic or boro reducing agent; catalyst selectivity |
| 03/30/2000 | WO2000017157A1 Optically active substituted n-aryl-o-aryloxyalkyl-carbamates |
| 03/30/2000 | WO2000017133A2 Lta4 hydrolase inhibitors |
| 03/30/2000 | WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/30/2000 | DE19843763A1 Optische aktive substituierte N-Aryl-O-aryloxyalkyl-carbamate Optically active N-substituted aryl-O-aryloxyalkyl-carbamate |
| 03/30/2000 | CA2345073A1 Optically active substituted n-aryl-o-aryloxyalkyl-carbamates |
| 03/30/2000 | CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/29/2000 | EP0988299A1 Polymerisable, optically active dioxolane diesters |
| 03/28/2000 | US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 03/28/2000 | US6043241 Ketoacid endothelin antagonists |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/28/2000 | CA2056662C Naphthoic acid derivative |
| 03/23/2000 | WO2000015599A1 Process for producing stereoselective nitro compounds |
| 03/22/2000 | EP0987261A1 Processes for producing dialdehyde monoacetals |
| 03/22/2000 | EP0986541A1 Process for covalently coupling organic compounds utilizing diboron derivatives |
| 03/22/2000 | EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/22/2000 | EP0830349B1 Method for preparing n, n'-disubstitued cyclic ureas |
| 03/22/2000 | CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides |
| 03/21/2000 | US6040464 Reacting a protected 1,2-dihydroxybutryamide in a hoffman rearrangement reaction mixture comprising a hypohalite, a base and solvent; chiral chemical intermediates: drugs, beta-blockers, phospholipids, liquid crystals |
| 03/21/2000 | US6040422 Reacting a fluoroformamidinium salt with an n-amino protected, optionally side chain protected amino acid; then reacting product with a carboxy protected amino acid; for compounds with long term storage stability |
| 03/21/2000 | US6040341 Compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 03/21/2000 | US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal |
| 03/21/2000 | US6040274 2-Aroylcyclohexanediones, their preparation and their use as herbicides or plant growth-regulating agents |
| 03/21/2000 | US6040107 Photosensitive diazonaphthoquinone esters based on selected cyclic alkyl ether-containing phenolics and their use in radiation sensitive mixtures |
| 03/16/2000 | WO2000014085A1 Oxygenic heterocyclic compounds |
| 03/16/2000 | WO2000014063A1 Therapeutic compounds and methods |
| 03/16/2000 | WO2000014033A1 The addition of oxygen nucleophiles to vinyl epoxides |
| 03/16/2000 | CA2342858A1 Method of screening compounds useful in the treatment of a desease caused by or exacerbated by mpv |
| 03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/15/2000 | EP0984914A1 Substituted 2-(3-alkenyl-benzoyl)-cyclohexane-1,3-diones |
| 03/15/2000 | CN1247535A Aminoepoxides from aminoaldehydes and in-situ formed halomethyl organometallic reagent |
| 03/14/2000 | US6037482 Process for catalytic addition of nucleophiles to alkynes or allenes |
| 03/14/2000 | US6037377 Antiinflammatory agents and antiallergens |
| 03/14/2000 | US6037365 Aminobenzamidinosuccinyl lactone derivatives useful as inhibitors of platelet aggregation |
| 03/14/2000 | US6037352 N-substituted piperidine derivatives; treating alzheimer*s disease, nervous system disorders; acetylcholinesterase inhibitors |
| 03/14/2000 | CA2045543C Iodinated esters |
| 03/09/2000 | WO2000012464A1 6-fluorobicyclo[3. 1.0]hexane derivatives |
| 03/09/2000 | WO2000012457A1 Catalytic synthesis of aldehydes by direct hydrogenation of carboxylic acids |
| 03/09/2000 | WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 03/09/2000 | CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 03/08/2000 | EP0984000A1 Process for producing amide derivatives and intermediate compounds |
| 03/08/2000 | EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 03/08/2000 | EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 03/08/2000 | EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 03/08/2000 | CN1246854A Process for manufacture of epoxy compounds |
| 03/02/2000 | WO2000010991A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs |
| 03/02/2000 | CA2341540A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs |
| 03/01/2000 | EP0982296A1 Perfuming and flavouring agents |
| 02/29/2000 | US6030967 And/or like neurotrophic factor (for example, nerve growth factor (ngf), brain-derived neurotrophic factor, neurotrophin-3, and glial cell line-derived neurotrophic factor)-like activity; osteoporosis |
| 02/24/2000 | WO2000009463A1 Stereoselective ring opening reactions |
| 02/24/2000 | CA2339618A1 Stereoselective ring opening reactions |
| 02/23/2000 | EP0794952B1 Polymerisable aromatic carboxylic acid and carboxylic acid anhydrides with cyclic carbonate groups and compositions that contain these compounds |
| 02/23/2000 | CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity |
| 02/23/2000 | CN1245166A Process for preparing 4,4'-diketo carotenoid |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028052 Treating NIDDM with RXR agonists |
| 02/22/2000 | CA2157248C Crystalline form of dihydro-2, 3 benzodiazepine derivative |
| 02/17/2000 | WO2000007981A1 Open chain alkoxyamine compounds and their use as polymerization regulators |
| 02/17/2000 | WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors |
| 02/17/2000 | WO2000007979A2 Compounds and compositions for delivering active agents |
| 02/17/2000 | WO2000007978A1 Aminomethylcarboxylic acid derivatives |
| 02/17/2000 | CA2337482A1 Open chain alkoxyamine compounds and their use as polymerization regulators |
| 02/16/2000 | CN1244527A Cyclic cedrene aldehyde acetal, its preparation and its use |
| 02/15/2000 | US6025504 Catalytic reaction between glycerol and urea, with removal of ammonia as it is formed |